Omnicell Inc (OMCL) — Analysis Summary
Omnicell Inc (OMCL) has a market cap of $1.51B with year-over-year revenue growth of +6.5%. Net margin stands at 0.2%. The stock trades at a P/E ratio of 38.6.
Key Takeaways
- Revenue changed +6.5% year-over-year
- Net margin of 0.2%
- P/E ratio of 38.6
Compared to other companies in the ELECTRONIC COMPUTERS sector, OMCL posted revenue growth of +6.5% and trades at a P/E of 38.6.
Omnicell Inc (OMCL)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Sector
ELECTRONIC COMPUTERS
Employees
3,485
Headquarters
FORT WORTH, TX
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.